In the study more than 3,000 participants with herpes simplex virus 2 were given either 400 milligrams of the anti-herpes medication acyclovir or a placebo twice daily. Results showed a 3.9% HIV incidence rate (75 cases) among participants who received acyclovir, compared to a 3.3% HIV incidence rate (64 cases) among the placebo group.
The research was considered particularly important because having herpes, one of the most common sexually transmitted diseases worldwide, almost triples a person's odds of acquiring HIV.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Health News You Should Know; herpes research counting on to reduce susceptibility to HIV infection|
|Publication:||The Advocate (The national gay & lesbian newsmagazine)|
|Article Type:||Brief article|
|Date:||Apr 8, 2008|
|Previous Article:||Should the Swiss stick to army knives and chocolate?|
|Next Article:||Gays and violence.|